Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04965116 · ClinicalTrials.gov registry record · Phase 4
Progestin-Only Pill Use and Breastfeeding Study
A Phase 4 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT04965116 is a Phase 4 study that has completed, run by University of California, San Diego. The registered enrollment target is 30 participants.
The verdict
NCT04965116, a Phase 4 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will assess the impact of early initiation (less than one week postpartum) and delayed initiation (4 weeks postpartum) of two types of progestin-only contraceptive pills (POPs) on maternal, breastmilk, and infant outcomes.
Interventions
- DRUG Progestin Only Contraceptive Pills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2022-11-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04965116
The ClinicalTrials.gov registry entry for NCT04965116 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Progestin Only Contraceptive Pills is the first listed.
NCT04965116 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04965116 about?
NCT04965116 is a clinical study titled "Progestin-Only Pill Use and Breastfeeding Study". This study will assess the impact of early initiation (less than one week postpartum) and delayed initiation (4 weeks postpartum) of two types of progestin-only contraceptive pills (POPs) on maternal, breastmilk, and infant outcomes.
What is the current status of trial NCT04965116?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2021-10-25. Estimated completion is 2022-11-04.
What interventions are being tested in trial NCT04965116?
The interventions under investigation include: Progestin Only Contraceptive Pills (DRUG).
Who is sponsoring clinical trial NCT04965116?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.